Keros Capital Update: Wellstone Filter Sciences Inc. (OTCBB: WFLR)
Wellstone Filter Sciences Inc. Applauds FDA Appointment
(EMAILWIRE.COM, September 02, 2009 ) Chapel Hill, North Carolina - Wellstone Filters (OTCBB: WFLR) applauds the appointment of Dr. Lawrence Deyton as Director of the new Center for tobacco Products. The Center's mission, according to the FDA is to, "use the best available science to guide the development and implementation of effective public health strategies to reduce the burden of illness and death caused by tobacco products."
For more than 15 years efforts have been made to bring tobacco products under FDA regulation. With the change in regulatory climate brought about by the Obama Administration, these efforts came to fruition with the recent passage of the Family Smoking Prevention and Tobacco Control Act. The legislation grants the U.S. Food and Drug Administration the authority to regulate the sale, manufacture, and marketing of tobacco products. Significantly for Wellstone, the legislation provides for a category of reduced risk tobacco products to be evaluated by the FDA and approved for marketing, in much the same way as drugs are approved for marketing.
Wellstone plans on submitting its patented Reduced Exposure Filter as the "best available technology" to the FDA in the weeks ahead.
With likely restrictions on advertising, marketing and packaging, the new legislation will favor companies that are first to market with alternatives offering significant reductions in toxins and carcinogens. The largest players in the tobacco space are Altria Group Inc. (NYSE: MO), Reynolds American, Inc. (NYSE: RAI), British American Tobacco (NYSE: BTI), Imperial Tobacco Group (OTC: ITYBY), Star Scientific Inc. (NASDAQ: STSI).
About The Company
Wellstone Filter Sciences, Inc., Inc. has developed and patented a "Reduced Exposure Product," or "REP" cigarette filter that reduces toxins and carcinogens without compromising taste. With over a decade of research and development, Wellstone is the only company specializing in Reduced Filter Products poised for new FDA oversight of Tobacco products.
Wellstone's filter technology has undergone several tests for efficacy including official FTC testing. Wellstone CEO Learned J. Hand stated, "We believe we possess the best available technology in the highly specialized field of REP technology."
Wellstone Filters can be found online at http://www.Wellstonefilter.com or http://www.wellstone-filters.com/
Disclosure: All material herein was prepared by Keros Capital Inc. (Keros) based upon information believed to be reliable. The information contained herein is not guaranteed by Keros to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Keros is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.keroscapital.com or mentioned herein. Keros has been compensated fifteen thousand dollars and one hundred fifty thousand shares for this advertising effort. Keros affiliates, officers, directors and employees may own shares and may buy and sell additional shares of the company mentioned herein and may profit in the event those shares rise in value. Keros will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
For more than 15 years efforts have been made to bring tobacco products under FDA regulation. With the change in regulatory climate brought about by the Obama Administration, these efforts came to fruition with the recent passage of the Family Smoking Prevention and Tobacco Control Act. The legislation grants the U.S. Food and Drug Administration the authority to regulate the sale, manufacture, and marketing of tobacco products. Significantly for Wellstone, the legislation provides for a category of reduced risk tobacco products to be evaluated by the FDA and approved for marketing, in much the same way as drugs are approved for marketing.
Wellstone plans on submitting its patented Reduced Exposure Filter as the "best available technology" to the FDA in the weeks ahead.
With likely restrictions on advertising, marketing and packaging, the new legislation will favor companies that are first to market with alternatives offering significant reductions in toxins and carcinogens. The largest players in the tobacco space are Altria Group Inc. (NYSE: MO), Reynolds American, Inc. (NYSE: RAI), British American Tobacco (NYSE: BTI), Imperial Tobacco Group (OTC: ITYBY), Star Scientific Inc. (NASDAQ: STSI).
About The Company
Wellstone Filter Sciences, Inc., Inc. has developed and patented a "Reduced Exposure Product," or "REP" cigarette filter that reduces toxins and carcinogens without compromising taste. With over a decade of research and development, Wellstone is the only company specializing in Reduced Filter Products poised for new FDA oversight of Tobacco products.
Wellstone's filter technology has undergone several tests for efficacy including official FTC testing. Wellstone CEO Learned J. Hand stated, "We believe we possess the best available technology in the highly specialized field of REP technology."
Wellstone Filters can be found online at http://www.Wellstonefilter.com or http://www.wellstone-filters.com/
Disclosure: All material herein was prepared by Keros Capital Inc. (Keros) based upon information believed to be reliable. The information contained herein is not guaranteed by Keros to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Keros is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.keroscapital.com or mentioned herein. Keros has been compensated fifteen thousand dollars and one hundred fifty thousand shares for this advertising effort. Keros affiliates, officers, directors and employees may own shares and may buy and sell additional shares of the company mentioned herein and may profit in the event those shares rise in value. Keros will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
Contact Information:
Wellstone Filter Sciences Inc.
Jim Mav
Tel: 908-464-1747
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
Wellstone Filter Sciences Inc.
Jim Mav
Tel: 908-464-1747
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
|
Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International Equityallianceir.com Penny Stocks to Watch Sign up for hot penny stock picks Gains of 500%+ possible! Premiumstockpicks.com/landing/ Your text Ads & PR Text Ads plus unlimited press releases, One release featured/Day for only $575 per month. Read more on Text Ads & PR Your text Ads Here! Text Ads are only $289 per month. Ads are placed same day. More on Text Ads Advertising |




